In The News
Stay informed with the latest research breakthroughs, treatment updates, and community stories related to Parkinson’s disease.
The Power of UConn Collaborating for Parkinson’s Disease Patients
July 29, 2026 | Lauren Woods UConn Health Parkinson's disease patients like Jose Figueroa are experiencing the power of a UConn-made protein shake being tested by the UConn research team in an FDA clinical study. Jose Figueroa, 66, of New Britain is “so grateful” for...
Turmeric compound may protect motor function in Parkinson’s mouse model
Preclinical study links curcumin’s effects to cellular recycling pathways Written by Marisa Horak, MS | Aug. 4, 2026 Curcumin pretreatment helped protect motor function in a Parkinson’s mouse model. It activated autophagy and reduced cuproptosis, a copper-dependent...
Storytelling language sheds light on Parkinson’s memory issues
Language analysis outperforms standard tests in spotting cognitive issues Written by Marisa Horak, MS | July 28, 2026 Language analysis of storytelling detected Parkinson's cognitive issues better than standard tests. Parkinson's patients showed reduced storytelling...
Training app paired with levodopa eases Parkinson’s symptoms
Hybridopa program leads to changes in brain networks involved in movement Written by Michela Luciano, PhD | July 28, 2026 Hybridopa, a digital app combined with levodopa, eased Parkinson's motor symptoms. This therapy induced structural and functional brain changes,...
Alzheimer’s may play limited role in early Parkinson’s cognitive problems
Study found no clear p-tau217 link in patients without dementia Written by Michela Luciano, PhD | July 29, 2026 The Alzheimer’s marker p-tau217 was not clearly linked to early cognitive problems in people with Parkinson’s who did not have dementia. Early cognitive...
Blood marker may help detect cognitive decline in Parkinson’s: Study
Specific ceramide ratio and inflammation combine to signal risk Written by Michela Luciano, PhD | July 30, 2026 A specific blood ceramide ratio is linked to worsening cognitive decline in Parkinson's disease. Higher levels of this ratio predict poorer cognitive...
US biotech secures $150M to develop potential treatments for Parkinson’s
1 therapy, bevemipretide, was shown to ease brain inflammation in mice Written by Andrea Lobo | July 16, 2026 Massachusetts-based biotech Mighty Therapeutics has raised $150 million to advance treatments for Parkinson's and other diseases. One drug in its pipeline is...
Once-daily therapy eases early Parkinson’s symptoms in Phase 3 trial
Study found benefits with tavapadon after 26 weeks of treatment Written by Margarida Maia, PhD | July 22, 2026 Tavapadon significantly eased motor symptoms and daily-function problems in people with early Parkinson’s. Benefits compared with a placebo were seen by week...
Doctors look beyond test scores to spot cognitive changes in Parkinson’s
Specialists weigh MoCA results alongside patients’ health information Written by Michela Luciano, PhD | July 21, 2026 Specialists assess cognitive impairment in Parkinson’s using MoCA performance patterns and patient health information Test results are interpreted...
Parkinson’s symptoms can make daily mouth care harder to maintain
Study highlights practical challenges, ways patients protect independence Written by Andrea Lobo | July 21, 2026 Parkinson’s symptoms, fatigue and balance problems can make daily mouth care difficult. Some patients are reluctant to accept help because they view mouth...